Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
328 DKK | -0.30% | +5.47% | +162.40% |
May. 07 | Gubra A/S Announces Management Changes | CI |
Apr. 17 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
Sales 2022 | 199M 29.01M | Sales 2023 | 205M 29.83M | Capitalization | 2.04B 296M |
---|---|---|---|---|---|
Net income 2022 | 4M 582K | Net income 2023 | -44M -6.4M | EV / Sales 2022 * | - |
Net cash position 2022 | 2.52M 367K | Net cash position 2023 | 386M 56.16M | EV / Sales 2023 | 8.05 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-42.6
x | Employees | 220 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 30.58% |
1 day | +0.46% | ||
1 week | +6.43% | ||
Current month | +8.88% | ||
1 month | +9.24% | ||
3 months | +57.62% | ||
6 months | +187.73% | ||
Current year | +164.80% |
Managers | Title | Age | Since |
---|---|---|---|
Niels Vrang
FOU | Founder | 56 | 07-12-31 |
Henrik Blou
CEO | Chief Executive Officer | 45 | 16-05-31 |
Kristian Borbos
DFI | Director of Finance/CFO | 46 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 21-12-31 | |
Director/Board Member | 48 | 21-12-31 | |
Jacob Jelsing
FOU | Founder | 50 | 07-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 328 | -0.30% | 21 501 |
24-05-30 | 329 | +3.13% | 24,569 |
24-05-29 | 319 | 0.00% | 9,248 |
24-05-28 | 319 | -0.62% | 28,063 |
24-05-27 | 321 | +3.22% | 18,249 |
Delayed Quote Nasdaq Copenhagen, May 31, 2024 at 08:54 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+164.80% | 779M | |
+8.92% | 114B | |
+10.48% | 105B | |
-6.45% | 23.83B | |
-3.38% | 21.73B | |
-10.19% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- GUBRA Stock